Market Currents
Endo Pharmaceuticals (ENDP -1.4%) slips on a downgrade to Hold at Cantor earlier today, citing a...
-
Wednesday, May 2, 2012, 3:37 PM ETEndo Pharmaceuticals (ENDP -1.4%) slips on a downgrade to Hold at Cantor earlier today, citing a mediocre Q1 and saying it sees no reason to buy the stock ahead of the the pending Lidoderm settlement.
Other date
HEALTHCARE ETFs IN FOCUS
Latest Healthcare Articles
